Palbociclib and Flibanserin: Interaction Details
- Flibanserin
- Addyi
- Palbociclib
- Ibrance
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Palbociclib and Flibanserin interaction:
What Happens When You Take Palbociclib With Flibanserin
What can happen when they are taken together (rated Major)
Increased exposure to with a
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Palbociclib is a weak, time-dependent CYP3A , so giving it together with a CYP3A substrate that has a narrow therapeutic index (NTI) can raise exposure to that substrate and worsen its adverse effects. In drug interaction studies, midazolam given alongside multiple doses of palbociclib showed higher and values. If the two are used together, a dose reduction of the CYP3A substrate should be considered, and patients should be monitored for toxicity.1
The Palbociclib and Flibanserin Interaction, Explained
Palbociclib (Ibrance) can slow down the way your body breaks down flibanserin (Addyi), so more flibanserin may stay in your body. Flibanserin is already known to cause dizziness, sleepiness, fainting, and low blood pressure. Having extra of it could make these effects stronger. This is based on how the drugs are expected to work (it is theoretical), and palbociclib is only a weak blocker of this process. Still, it is rated as a major interaction.
Keep taking both exactly as prescribed. Tell your pharmacist or doctor you use both. Your care team can adjust the dose if needed and may monitor you more closely.
Mechanism: Palbociclib is a weak, time-dependent . Flibanserin is primarily a (minor 2C19), so exposure (, ) may increase, raising the risk of , syncope, somnolence, and . Neither drug is a that changes this direction.
- Direction: increased substrate exposure.
- Evidence: theoretical for this pair; extrapolated from midazolam data showing increased AUC and Cmax with multiple-dose palbociclib.
- Onset: unspecified.
- Management: consider dose reduction of the CYP3A substrate if coadministered, and monitor for toxicity (blood pressure, , dizziness). Individualize therapy and confirm against current labeling for flibanserin.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Palbociclib and Flibanserin Interact
The likely mechanism
of by palbociclib
How to Manage the Palbociclib and Flibanserin Interaction
Your care team can manage this combination by tailoring your treatment and watching for side effects.
- Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
- Your team may consider a lower dose of flibanserin, individualized to you, and may monitor you more closely for side effects.
- Tell your pharmacist or prescriber right away about dizziness, unusual sleepiness, fainting, or lightheadedness.
- Check with them before starting or stopping any other medicine, supplement, or alcohol use.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Palbociclib or Flibanserin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: IBRANCE oral capsules, palbociclib oral capsules
In healthy subjects (N=26), giving midazolam (a ) together with multiple doses of palbociclib 125 mg/day raised the of midazolam by 61% and its by 37%.1
Palbociclib and Flibanserin: Common Questions
How serious is the Palbociclib and Flibanserin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Palbociclib and Flibanserin interaction managed?
Your care team can manage this combination by tailoring your treatment and watching for side effects. Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your team may consider a lower dose of flibanserin, individualized to you, and may monitor you more closely for side effects. Tell your pharmacist or prescriber right away about dizziness, unusual sleepiness, fain… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Palbociclib and Flibanserin Interaction
Ask in your own words about taking Palbociclib and Flibanserin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: IBRANCE(R) oral capsules, palbociclib oral capsules. Pfizer Labs (per FDA), New York, NY, 2019.
Other Serious Interactions of Palbociclib and Flibanserin
Also serious with Flibanserin
- ColchicineContraindicated
- Ketoconazole TopicalContraindicated
- Letermovir InjectionContraindicated
- AprepitantContraindicated
Also serious with Palbociclib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Flibanserin
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- KavaMajor
- WineMajor
- 1,4-butanediolMajor
- BeerMajor
- Gamma-hydroxybutyrate (GHB)Major
- + 196 more
With Palbociclib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- SeleniumModerate
- GingerModerate
- TurmericModerate
- AshwagandhaModerate
- + 182 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.